About AllCells

Donor Reservations

At AllCells, our mission is to support researchers and their groundbreaking discoveries in cell and gene therapy (CGT). By providing GMP and RUO products, custom donor management services, and integrated analytical capabilities, AllCells continues to be the preferred solutions provider for the CGT community and life science industry.

Our mission is to serve the industry through:

  • Tissue procurement to support basic research to commercialization
  • Access to 10,000+ recallable donors and scalable donor pools
  • Global network of apheresis collection centers
  • Reliable data from expert characterization and analytical services
  • Diseased biospecimens to support basic research and beyond
  • Donor recruitment and retention
  • Customizable tissue/cell collection protocols

Vision:

  • Deliver top quality products and services, as well as integrated analytical services, to support the entire CGT continuum–from basic discovery through commercialization
  • Establish partnerships with biomedical, pharmaceutical, and life science companies across the globe to deliver product solutions and streamlined supply chain logistics
  • Scale and enhance AllCells’ client-focused collection facilities, operational capacities, and donor networks to satisfy the growing needs of the CGT industry

AllCells’ Areas of Expertise:

  • Highly characterized RUO and GMP apheresis and marrow-derived products
  • Streamlined access to the largest commercial inventory of hyper-annotated™ diseased biospecimens
  • Robust and scalable donor network cell supply
  • Full pack/bulk immune cell isolations and made-to-order custom products
  • Expert cryopreservation methods and expansive cryopreserved inventory
  • Program-specific cell processing and technology transfers
  • Proprietary Donor Management System (DMS) and donor management services
  • Hyper-annotated™ reliable and recallable donor pool
  • Adherence to GMP Guidelines (21 CFR 1271) and eQMS framework
  • Expert project management and consulting services
  • FDA-registered, IRB-approved, AABB-compliant donor facilities
  • Integrated characterization and analytical services to support all stages of drug development

Our Promise

At AllCells, we understand that highly characterized and clinical grade starting materials are essential to support your cell and gene therapies. We are committed to help you bring innovative treatments to market faster by helping streamline CGT programs with GMP and RUO solutions.

The Right Cells

  • Access to 10,000+ recallable donors and scalable apheresis collection facilities
  • Extensive portfolio of GMP and RUO solutions for autologous and allogeneic programs
  • Quality, viability, and deliverability you can trust
  • Customizable tissue/cell collection protocols
  • Customized services to meet project requirements

At the Right Time

  • Fresh and cryopreserved shipments are available across the globe
  • Rapid and on-demand access to the right cellular starting materials
  • Deliverability of >98.5%
  • Highly communicative and collaborative team with < 24hr response time

AllCells Capabilities

  • Over 30 combined years of industry expertise in tissue procurement and cell processing
  • Comprehensive donor management services to efficiently recruit, screen, collect, monitor, and maintain essential donors
  • Global network of collection facilities for unparalleled access to reliable and recallable donors
  • Integrated analytical services to support CGT research, development, and manufacturing

History

Since its inception in 1998, AllCells has earned a reputation as the go-to provider of highly characterized primary cell and tissue products, supporting global biomedical organizations in our quest to develop and manufacture novel drugs and cell therapies. Leveraging decades of expertise in hematology and immunology cell isolations, combined with on-site tissue collection operations, AllCells is known for providing high quality source materials for a diverse range of applications.

In 2022, Discovery Life Sciences and AllCells joined forces to create one of the industry’s largest dedicated client donor pools. The collective global network of FDA-registered donor collection facilities, located adjacent to GMP cleanrooms and characterization labs, are complemented by the world’s largest commercial inventory of diseased, hyper-annotated™ biospecimens for optimized operations and accelerated timelines for our clients. The close proximity enables immediate processing and cryopreservation for unparalleled quality with the highest viability, purity, and cell count available. With more than 30 years of collective cell and gene therapy (CGT) experience, AllCells and Discovery will focus on providing revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum from basic discovery through commercialization to bring the vision of Science at your Service™ to life.

1998
2003
2007
2008
2010
2012
2013
2014
2016
2017
2018
2019
2020
2021
2022

AllCells Founded in Berkeley, California by Jay Tong, M.D.

Published first catalog offering a wide range of products and bioservices.

Delivered directly to local, domestic and global customers

Further diversified product portfolio by adding numerous CD34+ isolated cell products and fresh cord blood.

Achieved the “Fast 50 Award” award from the United States Pan Asian American Chamber of Commerce

Established IRB-approved, state-of-the-art donor facilities to collect cells and whole tissue from a large repository of recallable donors which enables custom orders to be fulfilled in the shortest time in the industry

Established IRB-approved, state-of-the-art donor facilities to collect cells and whole tissue from a large repository of recallable donors which enables custom orders to be fulfilled in the shortest time in the industry

Employed cutting-edge processing tools, such as AutoMACS and CliniMACs

Achieved the “Fast 50 Award” award from the United States Pan Asian American Chamber of Commerce

Ranked among the fastest growing privately owned United States companies by Inc. 500.

Relocated to AllCells existing Headquarters in Alameda, California.

Expansion of Worldwide market channels

Began delivering GMP Clinical Grade products to the biomedical research market.

Grand Opening of AllCells Boston offices.

Integrated enterprise systems solutions Oracle Netsuite.

Clinical Grade Donor Pool is launched.

Two Bi-Coastal Successful Collection Sites.

Lonza Partnership

Added Cryo Leukopaks to extensive cryopreserved portfolio

Grand Opening of AllCells Houston offices

GMP continued product expansion

Discovery Life Sciences acquires AllCells to create a new market leader in the procurement and customization of human cellular starting materials with integrated analytical services to advance cell and gene therapy programs.